GW-405833, a CB2-selective cannabinoid examined in this study, has been reported previously by others to impact expression levels of proteins involved in energy metabolism and cell growth in pancreatic adenocarcinoma, resulting in cell death [58]. Here, CNR2 is linked to pancreatic adenocarcinoma.